Singapore markets close in 7 hours 32 minutes
Straits Times Index
3,237.46 +24.82 (+0.77%) Nikkei
27,423.18 +37.93 (+0.14%) Hang Seng
19,915.68 0.00 (0.00%) FTSE 100
7,405.45 -94.15 (-1.26%) Bitcoin USD
27,877.54 +259.65 (+0.94%) CMC Crypto 200
607.22 -11.16 (-1.80%)
BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.51B |
| Enterprise value | 1.83B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | 5.50 |
| Price/book (mrq) | 56.59 |
| Enterprise value/revenue | 6.74 |
| Enterprise value/EBITDA | -12.70 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.03 |
| 52-week change 3 | -47.56% |
| S&P500 52-week change 3 | -13.21% |
| 52-week high 3 | 18.00 |
| 52-week low 3 | 7.61 |
| 50-day moving average 3 | 9.53 |
| 200-day moving average 3 | 11.62 |
Share statistics
| Avg vol (3-month) 3 | 3.03M |
| Avg vol (10-day) 3 | 2.84M |
| Shares outstanding 5 | 188.45M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 169.85M |
| % held by insiders 1 | 1.03% |
| % held by institutions 1 | 85.57% |
| Shares short (14 Mar 2023) 4 | 30.81M |
| Short ratio (14 Mar 2023) 4 | 8.05 |
| Short % of float (14 Mar 2023) 4 | 18.31% |
| Short % of shares outstanding (14 Mar 2023) 4 | 16.35% |
| Shares short (prior month 14 Feb 2023) 4 | 26.99M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Dec 2022 |
Profitability
| Profit margin | -91.25% |
| Operating margin (ttm) | -54.81% |
Management effectiveness
| Return on assets (ttm) | -16.30% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 270.83M |
| Revenue per share (ttm) | 1.46 |
| Quarterly revenue growth (yoy) | 68.70% |
| Gross profit (ttm) | 10.94M |
| EBITDA | -147M |
| Net income avi to common (ttm) | -247.12M |
| Diluted EPS (ttm) | -1.41 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 424.31M |
| Total cash per share (mrq) | 2.25 |
| Total debt (mrq) | 741.45M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 4.89 |
| Book value per share (mrq) | -1.57 |
Cash flow statement
| Operating cash flow (ttm) | -161.85M |
| Levered free cash flow (ttm) | -142.33M |
© 2023 Yahoo. All rights reserved.
